HEPARIN SODIUM INJECTION, USP
FRESENIUS KABI CANADA LTD
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of HEPARIN SODIUM INJECTION, USP in Canada?
A shortage of HEPARIN SODIUM INJECTION, USP 10000UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 14, 2026), but it has not started yet.
Why is HEPARIN SODIUM INJECTION, USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will HEPARIN SODIUM INJECTION, USP be available again?
The manufacturer's estimated resolution date is December 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
HEPARIN SODIUM INJECTION USP
PFIZER CANADA ULC
Other Products
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
PFIZER CANADA ULC
HEPARIN LEO 100UNIT/ML
LEO PHARMA INC
HEPARIN LEO INJ 1000UNIT/ML
LEO PHARMA INC
HEPARIN SODIUM INJECTION, USP
FRESENIUS KABI CANADA LTD
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
Estimated Resolution
2026-12-11
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02264307
Strength
10000UNIT
Dosage Form
SOLUTION
Route
SUBCUTANEOUS INTRAVENOUS
Active Ingredient
HEPARIN SODIUM
Tier
Unrated
Last Updated
2026-10-14
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02267659
3MG · DIN 02457474
3MG · DIN 02457482
50MG · DIN 02245248
500MG · DIN 02227010
250MG · DIN 02227029
1G · DIN 02227002